TAFLOTAN

This brand name is authorized in Germany, Estonia, Finland, Hong Kong, Lithuania, Poland, Singapore

Active ingredients

The drug TAFLOTAN contains one active pharmaceutical ingredient (API):

1 Tafluprost UNII 1O6WQ6T7G3 - TAFLUPROST

Tafluprost is a fluorinated analogue of prostaglandin F2α. Tafluprost acid, the biologically active metabolite of tafluprost, is a highly potent and selective agonist of the human prostanoid FP receptor. Read about Tafluprost

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01EE05	Tafluprost	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EE Prostaglandin analogues
Discover more medicines within S01EE05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 06707048, 06707054, 06707060, 09606945, 09606951, 10169332, 10169349, 10177739, 10177745, 10199209, 10199215, 11156828, 11156834, 11174306, 12641081, 12641098, 13703051, 13703068, 15317702, 15530324, 17633519
Country: EE	Ravimiamet	Identifier(s): 1379303, 1379314, 1753703, 1753714, 1870040, 1870051
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 134352, 134374, 152938, 199670
Country: HK	Department of Health Drug Office	Identifier(s): 59089, 63713
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1034197, 1038195, 1086684, 1086685, 1093207
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100170325, 100395515
Country: SG	Health Sciences Authority	Identifier(s): 13872P, 14856P